UCI Hematopoietic Stem Cell Transplant and Cellular Therapy Program
Location
101 The City Drive South
Orange, CA 92868
Direct phone: 714-456-7890
https://ucihealth.org/medical-services/bone-marrow-transplant
Total transplants by cell source
- Marrow: 12
- PBSC: 25
- Cord Blood: 0
- Autologous (PBSC or Marrow): 44
About the center
Overview
UCI Health Chao Family Comprehensive Cancer Center is expanding treatment options for cancers of the blood or lymph systems with the launch of Orange County's first adult bone marrow transplant program. Patients with diseases such as leukemia, lymphoma and multiple myeloma now can benefit from life-saving infusions of healthy blood stem cells. Called the Hematopoietic Stem Cell Transplant and Cellular Therapy Program, it also opens the way to emerging immunotherapy options, such as CAR T-cell therapy, for patients with many types of cancer. Our internationally recognized stem-cell transplant experts also provide full pre-and-post transplant follow-up, allowing patients to receive high-quality, seamless care close to home. And as Orange County's only National Cancer Institute-designated comprehensive cancer center, our patients also have access to early-phase clinical trials and advanced therapies before they are available elsewhere.
This center has been performing allogeneic transplants since 2020 and has been an NMDP/Be The Match transplant center since December 2023.
Attending physicians
Adult - Stephan Ciurea, Deepa Jeyakumar, Piyanuch Kongtim, Richard Van Etten
Transplants performed
Marrow/PBSC only
Cord blood transplants performed on
Not performed
Other programs and services
UCI Health also has a growing number of cellular therapy clinical trials for patients with hematological malignancies and solid tumors. Among the most promising is CAR T-cell therapy, an innovative treatment for certain blood cancers that is also being studied as a treatment for other cancer types.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 21 patients.
The actual 1-year survival of these patients is 81.0%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 58.5% and 92.6%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Total transplants
Total transplants
81
Transplants reported (From January 1, 2021 to December 31st, 2022 as reported by the centers)
Marrow | PBSC | Cord blood | Total | |
---|---|---|---|---|
Allogeneic | ||||
Related donor | 10 | 22 | 0 | 32 |
Unrelated donor | 2 | 3 | 0 | 5 |
Total allogeneic | 12 | 25 | 0 | 37 |
Autologous | ||||
Both marrow & PBSC 44 |
-- | 44 | ||
Total combined | ||||
81 | 0 | 81 |
Transplants by disease
All diseases
Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)
0-18 | 19-44 | 45-64 | 65+ | Total | |
---|---|---|---|---|---|
Related | 0 | 11 | 14 | 8 | 33 |
Unrelated | 0 | 1 | 2 | 2 | 5 |
Autologous | 0 | 14 | 16 | 17 | 47 |
Total | 0 | 26 | 32 | 27 | 85 |
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
- U.S. Transplant Data by Center report at bloodcell.transplant.hrsa.gov
- List of diseases
Additional information
Transplant center resources
Transplant center coordinator:
Kathy Majeski
714-509-2924
Email: kmajeski@hs.uci.edu
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
Email: patientinfo@nmdp.org